2021 annual financial data
Immuneering 2021 Financial results
Direct answer
Revenue was 2,079,961 USD.
Operating income was -33,886,069 USD and net income was -33,535,748 USD.
Operating cash flow was -30,850,882 USD.
Get free Immuneering email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,079,961 USD
- Operating income
- -33,886,069 USD
- Net income
- -33,535,748 USD
- Operating cash flow
- -30,850,882 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Immuneering financial years